Neointimal Healing Evaluated by Optical Coherence Tomography after Drug-Eluting Absorbable Metal Scaffold Implantation in de novo Native Coronary Lesions: Rationale and Design of the Magmaris-OCT Study

By  

Cardiology, Vol. 137, Iss. 4, 2017-05 ,pp. : 225-230

Karger

Access to resources Recommend Favorite

First‐in‐Man Study of the Low‐Dose Paclitaxel Using the COBRA‐P Drug‐Eluting Coronary Stent System With a Novel Biodegradable Coating in De Novo Coronary Lesions

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 84, Iss. 7, 2014-12 ,pp. : 1101-1109

John Wiley & Sons Inc

Access to resources Recommend Favorite

Assessment of Characteristics of Neointimal Hyperplasia after Drug-Eluting Stent Implantation in Patients with Diabetes Mellitus: An Optical Coherence Tomography Analysis

By  

Cardiology, Vol. 128, Iss. 1, 2014-02 ,pp. : 34-40

Karger

Access to resources Recommend Favorite

Distal Left Main Coronary Bifurcation Lesions Predict Worse Outcome in Patients Undergoing Percutaneous Implantation of Drug-Eluting Stents: Results from the Drug-Eluting Stent for the Treatment of Left Main Disease (DISTAL) Study

By  

Cardiology, Vol. 113, Iss. 4, 2009-02 ,pp. : 264-273

Karger

Access to resources Recommend Favorite

PLATINUM China: A prospective, randomized investigation of the platinum chromium everolimus‐eluting stent in de novo coronary artery lesions

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. S1, 2015-03 ,pp. : 716-723

John Wiley & Sons Inc

Access to resources Recommend Favorite